P-127: Patients with Multiple Myeloma on treatment with Anti-CD38 or Anti-BCMA agents have a suboptimal humoral response following COVID-19 vaccination
Title:
P-127: Patients with Multiple Myeloma on treatment with Anti-CD38 or Anti-BCMA agents have a suboptimal humoral response following COVID-19 vaccination
Author:
Terpos, Evangelos Gavriatopoulou, Maria Ntanasis-Stathopoulos, Ioannis Briasoulis, Alexandros Gumeni, Sentiljana Malandrakis, Panagiotis Fotiou, Despina Papanagnou, Eleni-Dimitra Migkou, Magdalini Theodorakakou, Foteini Roussou, Maria Eleutherakis-Papaiakovou, Evangelos Kanellias, Nikolaos Trougakos, Ioannis Kastritis, Efstathios Dimopoulos, Meletios-Athanasios